Literature DB >> 12648316

Two cases of delayed diagnosis of postpartal streptococcal toxic shock syndrome.

Wolfram Schummer1, Claudia Schummer.   

Abstract

BACKGROUND: Puerperal sepsis due to group A beta-hemolytic streptococcal (GAS) toxic shock syndrome is associated with very high morbidity and mortality. Luckily it is now rare, but diagnosis is not always easy. This report demonstrates the problem of recognizing this disease, and summarizes the current knowledge on the pathomechanism and management of streptococcal toxic shock syndrome. CASE: Two cases of postpartum streptococcal toxic shock syndrome due to GAS are described. In both cases the correct diagnosis was delayed for several days. The first patient was sent home with the diagnosis of German measles; the second patient was transferred to our neurological intensive care unit with the diagnosis of meningitis. Both patients were admitted to the intensive care unit in profound shock, both developed multiple organ failure, and one patient died.
CONCLUSIONS: GAS may produce virulence factors that cause host tissue pathology. Besides aggressive modern intensive care treatment, early diagnosis and correct choice of anti-streptococcal antibiotics are crucial. A possible adverse effect of non-steroidal anti-inflammatory agents requires confirmation in a multicenter study.

Entities:  

Mesh:

Year:  2002        PMID: 12648316      PMCID: PMC1784622          DOI: 10.1155/S106474490200025X

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  14 in total

1.  Contact activation in shock caused by invasive group A Streptococcus pyogenes.

Authors:  S Sriskandan; G Kemball-Cook; D Moyes; J Canvin; E Tuddenham; J Cohen
Journal:  Crit Care Med       Date:  2000-11       Impact factor: 7.598

2.  The ACCP-SCCM consensus conference on sepsis and organ failure.

Authors:  R C Bone; W J Sibbald; C L Sprung
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

Review 3.  Invasive group A streptococcus infections.

Authors:  D L Stevens
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

4.  Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome?

Authors:  D L Stevens
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

5.  Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome.

Authors:  D L Stevens
Journal:  Clin Infect Dis       Date:  1998-03       Impact factor: 9.079

6.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

Review 7.  Role of superantigens in human disease.

Authors:  P M Schlievert
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

8.  Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O.

Authors:  S P Hackett; D L Stevens
Journal:  J Infect Dis       Date:  1992-05       Impact factor: 5.226

9.  The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis.

Authors:  D L Stevens; A E Gibbons; R Bergstrom; V Winn
Journal:  J Infect Dis       Date:  1988-07       Impact factor: 5.226

10.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.

Authors:  H D Davies; A McGeer; B Schwartz; K Green; D Cann; A E Simor; D E Low
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

View more
  2 in total

1.  Group A Streptococcus Septic Shock after Surgical Abortion: A Case Report and Review of the Literature.

Authors:  Stephanie C Tardieu; Elizabeth Schmidt
Journal:  Case Rep Obstet Gynecol       Date:  2017-09-11

2.  Ovarian necrosis due to S. pyogenes septic thrombophlebitis: A case report.

Authors:  Alicia Guntiñas; Janette L Kirk; M Teresa Blanco; Javier Pérez-Pedregosa; Miguel A Rodríguez
Journal:  Case Rep Womens Health       Date:  2018-09-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.